vs

Side-by-side financial comparison of C.H. Robinson (CHRW) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

C.H. Robinson is the larger business by last-quarter revenue ($3.9B vs $2.1B, roughly 1.9× Zimmer Biomet). Zimmer Biomet runs the higher net margin — 11.4% vs 3.5%, a 7.9% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs -6.5%). C.H. Robinson produced more free cash flow last quarter ($302.4M vs $245.9M). Over the past eight quarters, Zimmer Biomet's revenue compounded faster (3.7% CAGR vs -5.8%).

C.H. Robinson Worldwide, Inc. is an American transportation company that includes third-party logistics (3PL). The company offers freight transportation, transportation management, brokerage and warehousing. It offers truckload, less than truckload, air freight, intermodal, and ocean transportation.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

CHRW vs ZBH — Head-to-Head

Bigger by revenue
CHRW
CHRW
1.9× larger
CHRW
$3.9B
$2.1B
ZBH
Growing faster (revenue YoY)
ZBH
ZBH
+15.8% gap
ZBH
9.3%
-6.5%
CHRW
Higher net margin
ZBH
ZBH
7.9% more per $
ZBH
11.4%
3.5%
CHRW
More free cash flow
CHRW
CHRW
$56.5M more FCF
CHRW
$302.4M
$245.9M
ZBH
Faster 2-yr revenue CAGR
ZBH
ZBH
Annualised
ZBH
3.7%
-5.8%
CHRW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CHRW
CHRW
ZBH
ZBH
Revenue
$3.9B
$2.1B
Net Profit
$136.3M
$238.3M
Gross Margin
64.6%
Operating Margin
4.6%
17.9%
Net Margin
3.5%
11.4%
Revenue YoY
-6.5%
9.3%
Net Profit YoY
-8.7%
30.5%
EPS (diluted)
$1.12
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHRW
CHRW
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$3.9B
$2.2B
Q3 25
$4.1B
$2.0B
Q2 25
$4.1B
$2.1B
Q1 25
$4.0B
$1.9B
Q4 24
$4.2B
$2.0B
Q3 24
$4.6B
$1.8B
Q2 24
$4.5B
$1.9B
Net Profit
CHRW
CHRW
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$136.3M
$139.4M
Q3 25
$163.0M
$230.9M
Q2 25
$152.5M
$152.8M
Q1 25
$135.3M
$182.0M
Q4 24
$149.3M
$239.5M
Q3 24
$97.2M
$249.1M
Q2 24
$126.3M
$242.8M
Gross Margin
CHRW
CHRW
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
CHRW
CHRW
ZBH
ZBH
Q1 26
17.9%
Q4 25
4.6%
6.9%
Q3 25
5.3%
17.6%
Q2 25
5.2%
14.4%
Q1 25
4.4%
15.3%
Q4 24
4.4%
19.2%
Q3 24
3.9%
15.3%
Q2 24
4.0%
18.1%
Net Margin
CHRW
CHRW
ZBH
ZBH
Q1 26
11.4%
Q4 25
3.5%
6.2%
Q3 25
3.9%
11.5%
Q2 25
3.7%
7.4%
Q1 25
3.3%
9.5%
Q4 24
3.6%
11.8%
Q3 24
2.1%
13.7%
Q2 24
2.8%
12.5%
EPS (diluted)
CHRW
CHRW
ZBH
ZBH
Q1 26
$1.22
Q4 25
$1.12
$0.71
Q3 25
$1.34
$1.16
Q2 25
$1.26
$0.77
Q1 25
$1.11
$0.91
Q4 24
$1.23
$1.18
Q3 24
$0.80
$1.23
Q2 24
$1.05
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHRW
CHRW
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$160.9M
$424.2M
Total DebtLower is stronger
$1.1B
$7.5B
Stockholders' EquityBook value
$1.8B
$12.7B
Total Assets
$5.1B
$22.7B
Debt / EquityLower = less leverage
0.59×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHRW
CHRW
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$160.9M
$591.9M
Q3 25
$136.8M
$1.3B
Q2 25
$156.0M
$556.9M
Q1 25
$129.9M
$1.4B
Q4 24
$145.8M
$525.5M
Q3 24
$131.7M
$569.0M
Q2 24
$113.2M
$420.1M
Total Debt
CHRW
CHRW
ZBH
ZBH
Q1 26
$7.5B
Q4 25
$1.1B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.6B
Q2 24
$1.6B
Stockholders' Equity
CHRW
CHRW
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$1.8B
$12.7B
Q3 25
$1.9B
$12.8B
Q2 25
$1.8B
$12.5B
Q1 25
$1.7B
$12.4B
Q4 24
$1.7B
$12.5B
Q3 24
$1.6B
$12.4B
Q2 24
$1.5B
$12.7B
Total Assets
CHRW
CHRW
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$5.1B
$23.1B
Q3 25
$5.2B
$23.5B
Q2 25
$5.3B
$22.9B
Q1 25
$5.2B
$22.2B
Q4 24
$5.3B
$21.4B
Q3 24
$5.6B
$21.7B
Q2 24
$5.5B
$21.5B
Debt / Equity
CHRW
CHRW
ZBH
ZBH
Q1 26
0.59×
Q4 25
0.59×
Q3 25
0.64×
Q2 25
0.76×
Q1 25
0.80×
Q4 24
0.80×
Q3 24
0.95×
Q2 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHRW
CHRW
ZBH
ZBH
Operating Cash FlowLast quarter
$305.4M
$359.4M
Free Cash FlowOCF − Capex
$302.4M
$245.9M
FCF MarginFCF / Revenue
7.7%
11.8%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
2.24×
1.51×
TTM Free Cash FlowTrailing 4 quarters
$894.9M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHRW
CHRW
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$305.4M
$517.4M
Q3 25
$275.4M
$418.7M
Q2 25
$227.1M
$378.2M
Q1 25
$106.5M
$382.8M
Q4 24
$267.9M
$506.3M
Q3 24
$108.1M
$395.7M
Q2 24
$166.4M
$369.4M
Free Cash Flow
CHRW
CHRW
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$302.4M
$442.6M
Q3 25
$269.5M
$363.7M
Q2 25
$219.8M
$328.1M
Q1 25
$103.2M
$338.2M
Q4 24
$265.3M
$454.8M
Q3 24
$103.3M
$351.2M
Q2 24
$159.8M
$316.7M
FCF Margin
CHRW
CHRW
ZBH
ZBH
Q1 26
11.8%
Q4 25
7.7%
19.7%
Q3 25
6.5%
18.2%
Q2 25
5.3%
15.8%
Q1 25
2.5%
17.7%
Q4 24
6.3%
22.5%
Q3 24
2.2%
19.3%
Q2 24
3.6%
16.3%
Capex Intensity
CHRW
CHRW
ZBH
ZBH
Q1 26
Q4 25
0.1%
3.3%
Q3 25
0.1%
2.7%
Q2 25
0.2%
2.4%
Q1 25
0.1%
2.3%
Q4 24
0.1%
2.5%
Q3 24
0.1%
2.4%
Q2 24
0.1%
2.7%
Cash Conversion
CHRW
CHRW
ZBH
ZBH
Q1 26
1.51×
Q4 25
2.24×
3.71×
Q3 25
1.69×
1.81×
Q2 25
1.49×
2.48×
Q1 25
0.79×
2.10×
Q4 24
1.79×
2.11×
Q3 24
1.11×
1.59×
Q2 24
1.32×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHRW
CHRW

North American Service Transportation NAST$2.8B72%
Global Forwarding$731.0M19%
Sourcing$340.9M9%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons